Advanced Enzyme Technologies Limited has informed stock exchanges about its upcoming conference call with analysts and investors scheduled for May 12, 2026 at 09:00 AM IST. The call will focus on discussing the company’s financial results for the quarter and year ended March 31, 2026.

The announcement has been made under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations 2015, ensuring proper disclosure to investors and market participants.

Purpose of the conference call

The main objective of the conference call is to provide investors with detailed insights into the company’s FY26 financial performance and business outlook.

During the call, management is expected to cover:

• Quarterly and annual financial performance
• Revenue and profitability trends
• Operational highlights and business developments
• Market demand and industry outlook
• Strategic plans for future growth

Such interactions help investors understand the company’s performance beyond financial statements.

Senior management participation

The conference call will feature participation from senior leadership, including:

• Whole-time Director Mr. Mukund Kabra
• Chief Financial Officer Mr. Beni Prasad Rauka

The session will allow analysts and investors to directly engage with management and seek clarifications on financial results and business strategy.

The call is being organised with dial-in access for both domestic and international participants, along with pre-registration options to ensure smoother participation.

Company overview and business focus

Advanced Enzyme Technologies Limited is a leading player in the enzyme manufacturing and biotechnology sector. The company develops and supplies enzyme products used in:

• Food processing industries
• Animal nutrition applications
• Pharmaceutical formulations
• Industrial and specialty applications

The company operates with a strong focus on research and development, innovation, and global market expansion.

Importance of earnings conference calls

Earnings conference calls play an important role in listed companies as they provide a direct communication channel between management and investors.

Key benefits include:

• Clear explanation of financial results
• Direct interaction with senior management
• Transparency in business outlook
• Better understanding of industry conditions
• Improved investor confidence

For companies in science and technology-driven sectors like enzymes, such calls help explain technical and financial performance in a structured way.

Expected discussion areas for FY26 results

Investors and analysts are likely to focus on:

• Revenue growth across domestic and international markets
• Margin performance and cost efficiency
• R&D investments and new product development
• Export performance and global demand trends
• Outlook for enzyme-based solutions in key industries

Management may also provide guidance on future expansion plans and innovation strategy.

Regulatory compliance and disclosure importance

The announcement has been made in compliance with SEBI LODR Regulation 30, which requires listed companies to disclose material events that may impact investor decision-making.

This ensures:

• Equal access to information for all investors
• Transparency in corporate communication
• Timely dissemination of financial updates
• Strong corporate governance practices

Advanced Enzyme Technologies continues to follow structured disclosure practices in line with regulatory expectations.

Investor access and participation details

The conference call will be accessible through:

• Primary dial-in numbers for domestic participants
• International toll-free access numbers
• Pre-registration links for reduced waiting time
• Participant PIN for international attendees

This ensures wide accessibility for global investors and analysts interested in the company’s performance.

Industry relevance and growth outlook

The enzyme industry is driven by increasing demand for:

• Natural and sustainable processing solutions
• Food and beverage innovation
• Health and nutrition products
• Industrial efficiency improvements

Advanced Enzyme Technologies operates in a niche segment that benefits from global trends toward biotechnology and sustainable industrial processes.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.